Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinical profile of patient with mitral plasty and mitral valve replacement

From: Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier

Variables MPL(n = 214) MVR(n = 141)
Age yrs 64(54–72) 62(51–69)*
EF in % 60(50–73) 50(50–63)*
Female 59 59
Presence of Dyspnea 201 133
Presence of angina 43 28
Presence of MR 203 127
Mild Grad-I 3 1
Moderate Grad-II 15 27
Severe Grad-III 181 99
Presence of MR + MS 11 14
Presence of AF 54 55
Presence of AR 25 40
Presence of AS 14 26
Presence of TR 30 31
Presence of PR 2 2
3 vessels disease 32 19
Significant CHD 62 43
Etiology/Pathology   
Barlow 4 2
Myxoma 1 0
Ischemic MR 29 21
Endocarditis 21 26
Degenerative 120 13
Unknown etiology 46 34
Papillary muscle rupture 10 7
Valve thrombosis 0 1
Previous valve surgery   
Previous MVR 2 10
Previous AVR 3 5
Previous plasty 1 3
  1. MS Mitral Stenosis, AF Atrial Fibrillation, AS Aortic Stenosis, TR, Tricuspid regurgitation.
  2. PR Pulmonary valve regurgitation, AR Aortic regurgitation, (*) Median and interquartile interval.
  3. Significant CHD: Major stenosis over 75% in one of the major coronary artery.